Skip to main content
. Author manuscript; available in PMC: 2013 Oct 3.
Published in final edited form as: Pharm Res. 2010 Nov 25;28(3):662–672. doi: 10.1007/s11095-010-0322-4

Fig. 5.

Fig. 5

Dose response anti-inflammatory effects of GLP1-SSM in comparison to methylprednisolone. ac BALF neutrophil cell count a lung tissue MPO (mOD/min/g of tissue) assay activity b and BALF IL-6 concentration c in ALI mice at increasing peptide dose of s.c. GLP1-SSM (5–30 nmol/mouse) or methylprednisolone (3 mg/kg). * indicates p<0.05 compared to saline, SSM and GLP-1 treatment groups. #, + indicate p< 0.05 compared to GLP1-SSM 5 nmol and GLP1-SSM 15 nmol respectively (n=6/group).

HHS Vulnerability Disclosure